Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

RabeprazoleÀ» Æ÷ÇÔÇÑ 3Á¦¿ä¹ýÀÇ Ç︮ÄÚ¹ÚÅÍ ÆÄÀ̷θ® Á¦±Õ È¿°ú¿Í CYP2C19 À¯ÀüÀÚÇüÀÇ ¿µÇâ Efficacy of Triple Therapy with Rabeprazole for Helicobacter pylori Infection in relation to CYP2C19 Genotype

´ëÇѼÒÈ­±âÇÐȸÁö 2003³â 42±Ç 6È£ p.468 ~ 475
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ»ó¹è/Lee SB ¹Ú»óÁ¾/·ùÁö°ï/ÀÌÁø±¤/±èȸÁø/¹èÁø¼ö/Á¤Çö½Â/¹Ú½Ç¹«/Park SJ/Ryu JK/Lee JK/Kim HJ/Bae JS/Jung HS/Park SM

Abstract

[ÃʷϾøÀ½:No abstract]

Å°¿öµå

CYP2C19; Helicobacter pylori; Proton pump inhibitor; Rabeprazole

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS